BackKailera Therapeutics Overview

Kailera Therapeutics Current Assets

Kailera Therapeutics's current assets is $930M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$929.17M

Peer trimmed avg / median

Loading

Kailera Therapeutics Current Assets History

Loading

Kailera Therapeutics vs. peers: Current Assets Comparison

Loading

Kailera Therapeutics Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Kailera Therapeutics (KLRA) FAQ

The latest current assets for KLRA is $930M as of June 2026. Investors often review this figure alongside Kailera Therapeutics's historical trend and sector peers before judging valuation or financial health.

A current assets figure of $930M for KLRA is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting KLRA's current assets ($930M), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Kailera Therapeutics's current assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.